
    
      Subjects will be enrolled in a multicenter, longitudinal observational study.
      Parents/subjects will provide their Informed Consent/assent to upload their data for
      population-based analyses and, ultimately, clinical outcomes. Adherence data will be
      primarily derived from the easypod™ device combined with physician data entry of outcome
      measures. Data will be collected retrospectively and prospectively. This will allow the
      establishment of adherence profiles and subsequent clinical outcomes. Collected data will be
      also analyzed in a multinational pooled analysis of comparable national studies.

      Primary Objective:

      - To assess the level of adherence of subjects receiving SAIZEN® via easypod™

      Secondary Objectives:

        -  To describe the impact of adherence on clinical outcomes for subject receiving SAIZEN®
           via easypod™

        -  To identify adherence subject profiling

        -  To asses the impact of adherence on Insulin-like Growth Factor 1 (IGF1) (i.e. above,
           below or within normal ranges)
    
  